Large-scale testing of women in Copenhagen has not reduced the prevalence of Chlamydia trachomatis infections  H. Westh, H.J. Kolmos  Clinical Microbiology.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
C. Steininger, M. Redlberger, W. Graninger, M. Kundi, T. Popow-Kraupp 
High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study  H.L. Nielsen, T. Ejlertsen, J. Engberg,
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
Approach to diagnosis of infective endocarditis
Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population  D. Nowakowska,
Herpes zoster in non-hospitalized children
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Atypical respiratory pathogens
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects  K. Ekelund, P. Skinhøj, J. Madsen, H.B.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
G. Griesinger, G. Gille, C. Klapp, S. von Otte, K. Diedrich 
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Toxoplasmic lymphadenitis—clinical and serologic profile
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca  N. Moustaoui,
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay  P. Jokela,
T. Lazzarotto, B. Guerra, L. Gabrielli, M. Lanari, M.P. Landini 
Laboratory diagnosis and biosafety issues of biological warfare agents
Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium  M. Denton, M.J. Hall, N.J.
Uncommon opportunistic fungi: new nosocomial threats
Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product  T.G. Bromage  Clinical Microbiology.
C.G. Teo  Clinical Microbiology and Infection 
Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region  K.B. Laupland, M.D. Parkins, T. Ross, J.D.D. Pitout 
A retrospective study into the prevalence of herpes simplex virus 1&2 in female patients tested for Chlamydia trachomatis and/or Neisseria gonorrhoeae.
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study  H.L. Nielsen, T. Ejlertsen, J. Engberg,
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
G.R. Davies  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle.
Community-acquired pneumonia: epidemiologic and clinical consideration
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
Fibronectin concentrations in catheter sepsis
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
A. Norberg, C.E. Nord, B. Evengård  Clinical Microbiology and Infection 
Brita Bruun, Henrik Westh, Jørgen Stenderup 
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
Survival of rhinoviruses on human fingers
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
D. Baud, C. Kebbi, J.-P. Külling, G. Greub 
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
G.C. Schito  Clinical Microbiology and Infection 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
The future of diagnostic bacteriology
Presentation transcript:

Large-scale testing of women in Copenhagen has not reduced the prevalence of Chlamydia trachomatis infections  H. Westh, H.J. Kolmos  Clinical Microbiology and Infection  Volume 9, Issue 7, Pages 619-624 (July 2003) DOI: 10.1046/j.1469-0691.2003.00554.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 The age-specific percentage of women in Copenhagen examined every year at least once for chlamydial infection (median and range for the years 1995–99). Clinical Microbiology and Infection 2003 9, 619-624DOI: (10.1046/j.1469-0691.2003.00554.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 The positive sample rate for detection of Chlamydia trachomatis infections in women aged 15–49 years in Copenhagen (CPH), Denmark for the years 1995–99 (median and range). Also shown are the total number of women of each age (average of the 5-year period) living in Copenhagen and the percentage of Danish women of a given age living in Copenhagen. Clinical Microbiology and Infection 2003 9, 619-624DOI: (10.1046/j.1469-0691.2003.00554.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 The performance of EIA with a sensitivity of 80% and a specificity of 99% compared with a genomic detection assay with a sensitivity of 95% and a specificity of 99.5%. The positive predictive value (PPV) and negative predictive value (NPV) of a test result were calculated using the sensitivities and specificities of the tests and the age-specific estimate of prevalence of chlamydial infection from Figure 2. Clinical Microbiology and Infection 2003 9, 619-624DOI: (10.1046/j.1469-0691.2003.00554.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 The average number of Chlamydia trachomatis infections diagnosed per age and the estimated impact of change of detection method to genomic detection (data from 1995 to 1999 combined into one graph). For comparison, the calculated maximum number of women with C. trachomatis infection in Copenhagen is shown. The calculated maximum is based on the average of the years 1995–99 and the assumption that the prevalence of C. trachomatis infections in all women is the same as the positive rate found by large-scale opportunistic testing of 19.3% of the female population per year. Clinical Microbiology and Infection 2003 9, 619-624DOI: (10.1046/j.1469-0691.2003.00554.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions